James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

These Are Buys, Four-Digit P/E’s Be Damned!

Sometimes, an outrageously high valuation is worth the high price of entry -- as is true for these four stocks. Take a look at our four-digit P/E portfolio.

Accenture’s Dip: An Opportunity, Not an Omen

Sometimes, investors' first reactions to an earnings report can be off-track. Accenture's (slightly) disappointing quarter doesn't make this stock a loser.

Forget Alcoa — This Company Is a Better Earnings Barometer

Alcoa's results are often used as barometer of earnings success, but that’s an antiquated (and possibly dangerous) assumption. Here's who to watch instead.

What’s Next for Apple Stock? $600 … or $400?

Counterintuitive as it might be, the fact that analysts have gone sour on Apple stock might be the best indication that AAPL will be OK.

Chemical Stocks: 2 to Buy, 2 to Sell

Two chemical makers might be worth a swing right now before the spotlight shines on the sector again; two others should be avoided.